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Abstract
Background: Chronic exposure to mild irritants including cleansing and antiseptic products used
for hand hygiene generates insults to the skin. To avoid unpleasant reactions, skin protection
creams are commonly employed, but some fail to afford protection against a variety of xenobiotics.
In this study, two skin protection creams were assayed comparatively looking for a protective
effect if any against a liquid soap and an alcohol-based gel designed for hand hygiene in medical
settings.
Methods:  Corneosurfametry and corneoxenometry are two in vitro bioessays which were
selected for their good reproducibility, sensitivity and ease of use. A Kruskal-Wallis ANOVA test
followed by the Dunn test was realized to compare series of data obtained.
Results: Significant differences in efficacy were obtained between the two assayed skin protection
creams. One of the two tested creams showed a real protective effect against mild irritants, but
the other tested cream presented an irritant potential in its application with mild irritants.
Conclusion: The differences observed for the two tested skin protection creams were probably
due to their galenic composition and their possible interactions with the offending products. As a
result, the present in vitro bioassays showed contrasted effects of the creams corresponding to
either a protective or an irritant effect on human stratum corneum.
Introduction
The regular and repetitive use of cleansing and antiseptic
products for hand hygiene in medical settings is typically
at risk for inducing irritant contact dermatitis (ICD) [1-3].
Indeed, repeat chemical aggressions generate subclinical
alterations of the stratum corneum (SC), and impair the
natural barrier against various chemical xenobiotics and
microorganisms. As a result, skin becomes imperceptibly
harsh and ICD ensues.
In order to minimize the risk for developing ICD, prophy-
lactic measures are offered including the application of
skin protection creams (SPC) [4]. SPC are marketed for
preventing or reducing the adsorption, penetration and
absorption of irritants into the skin [4-6]. In practice, their
use remains subject to a lively debate. In general, there is
a lack of evidence of their efficacy. Some authors even sug-
gest that inappropriate SPC applications are prone to
induce additional irritation rather than benefit [7-9].
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Various in vivo and vitro methods were developed in
recent times for evaluating SPC efficacy [10-16]. Each of
the methods probably presents some advantages but also
disadvantages. In vitro methods are generally recom-
mended for screening SPC efficacy because of their ease,
speed, and safety. Indeed, the interpretation of in vivo
testing may be clouded by large inter-individual differ-
ences.
Two bioassays, namely corneosurfametry and corneoxe-
nometry [17-24], were designed for comparing SPC effi-
cacy. Both methods entail collection of human SC to serve
as substrate for testing the ex-vivo reactivity of xenobiotics
with human tissue. Any noxious xenobiotic is placed at a
given concentration in contact with the SC for a defined
period of time. After rinsing, specific dyes are applied to
the samples. The staining intensity is proportional to the
removal and/or degradation of SC proteins and lipids.
The colour of the samples is measured by reflectance
colorimetry. The recorded value is indicative of the sever-
ity of the damage induced by the xenobiotic to the SC or,
conversely, can be representative of the effect brought by
a SPC [21].
The aim of the present study was to compare the efficacy
of two SPC using corneosurfametry and corneoxenome-
try. The potentially noxious products were regular cleans-
ing and antiseptic products used for hand hygiene in
medical settings.
Materials and methods
This study was performed in accordance with the Declara-
tion of Helsinki and its subsequent amendments.
Informed consent was obtained after the nature of the
procedure had been fully explained. A total of 18 adults of
both genders aged 18 to 55 years were enrolled. In each
subject a series of 7 cyanoacrylate skin surface strippings
(CSSS) were harvested from the volar aspect of each fore-
arm. Their size reached 1.5* 3 cm.
The range of products tested in this study was prepared by
Naqi (Halen, Belgium). There were designed to be used
for hand hygiene. The specific claims for these products
were rapid cleansing, disinfection and repair of the skin
barrier. They presented as an alcohol-based gel and a liq-
uid soap. Two SPC identified as SPC 1 and SPC 2 were
assayed. The specific product compositions are listed in
Table 1.
Five CSSS harvested from five different volunteers were
used for testing each potentially irritant xenobiotic. In
order to mimick the regular use of these products, the liq-
uid soap was used at a 1:1 water dilution, and the alcohol-
based gel was used as a neat formulation. Each of the 5
CSSS was dipped for 10 min into a flask containing one of
the given xenobiotics. After rinsing in running tap water,
they were air-dried and stained for 1 min in a 30% hydro-
alcoholic solution of toluidine blue and basic fuschin.
The colour of the CSSS was measured by reflectance color-
imetry in the CIELab system using a Chroma Meter® CR
400 (Minolta, Osaka, Japan). The colorimetric index of
mildness (CIM), representing the staining intensity, was
calculated as previously described [23,24] following CIM
= L* – Chroma C*
Previous studies indicated that CIM value decreased with
increasing chemical alteration of the corneocytes. CIM
reached about 65 – 70 for water-treated CSSS, and
decreased down to zero or below with increasing aggres-
siveness of products against corneocytes [17].
In addition, the alcohol-based gel and the liquid soap
were tested singly following repetitive dipping contacts. A
10-min contact time was secured and repeated 4 times. A
10-min rest period was respected between successive dip-
ping procedures. During each rest period products were
rinsed under running tap water for 1 min followed by air
drying at room temperature. A similar design was fol-
lowed combining successive applications of the liquid
Table 1: Composition of the Naqi products used in the study.
Alcohol gel
Alcool, Aqua, Polyquaternium-37, Glycerin, Panthenol, PEG-7 glyceryl cocoate, Cyclomethicone, PPG-15-stearyl ether, Parfum, Lactic acid
Liquid soap
Aqua, Sodium laureth sulphate, Sodium laureth-11 carboxylate, PEG-7 glyceryl cocoate, PEG-4-rapeseedamide, Sodium chloride, Polysorbate 21, 
Lauryldimonium Hydroxypropyl, Hydrolyzed Wheat Protein, Laureth-10, Panthenol, Laureth-4, PEG-150 Distearate, Allantoin, Parfum, 
Phenoxyethanol, Methylparaben, Ethylparaben, Propylparaben, Butylparaben, Disodium EDTA
Skin protection cream 1
Aqua, Butyrospermum Parkii, Cetearyl Octanoate, Propylene Glycol, Sorbitan stearate, Dimethicone, Cetearylalcohol, Cyclomethicone, 
Trimethylsiloxysilicate, PPG-(15)-stearyl ether, Panthenol, Bisabolol, Allantoin, Sucrose cocoate, Xhantan Gum, Methylparaben, Propilparaben, 
Imidiazolidinyl Urea, Propylapraben, Imidazolidinyl Urea, Parfum, Tocopherol, EDTA
Skin protection cream 2
Aqua, Butyrospermum Parkii, Simmondsia Chinensis, Oxidized Corn Oil, Pentaerythrityl Tetracaprylate/Caprate, Glycerin, Cetyl esters, Octyl 
Stearate, Cetearylalcohol, Sucrose laurate, Sucrose Erucate, Bisabolol, Phenoxyethanol, Ethylhexylglycerin, Carbomer, Sodium Hydroxide, 
Trisodium Ethylenediamine Disuccinate, Inulin Lauryl Carbamate, Xanthan Gum, Parfum, Tocopherol.Journal of Occupational Medicine and Toxicology 2008, 3:15 http://www.occup-med.com/content/3/1/15
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soap followed by the alcohol-based gel in a 4 repeat con-
tact procedure.
In order to assess BC efficacy and their skin tolerance, a
beforehand uniform SPC application was performed on
the CSSS before initiating the ex-vivo cumulative irritancy
tests described here above. SPC 1 and SPC 2 were tested
on different series of CSSS for evaluating their protective
effect against repetitive use the liquid soap and the alco-
hol-based gel. Controls consisted in similar testing with-
out BC applications.
Statistical analysis
All statistical evaluations were performed using the Instat
2.01, 1993 GraphPad software Macintosh. The Shapiro-
Wilk test was used to assess the possible normality of data
distribution. Due to the non Gaussian distribution of CIM
values, they were summarized as medians and ranges.
Comparisons between series of data were made using the
unpaired non-parametric Kruskal-Wallis ANOVA test fol-
lowed by the Dunn test. A p-value lower than 0.05 was
considered statistically significant.
Results
Ex vivo cumulative irritancy test
All CIM values obtained after a single or repeat contacts
with the liquid soap were above 40 indicating a good skin
tolerance (Table 2). There was no significant difference
with increasing the number of contacts with the liquid
soap. Only a trend in median CIM decrease was yielded
after 3 and 4 contacts. CIM median values in the range
30–45 yielded for the alcohol-based gel suggested a fairly
good skin tolerance (Table 2). No statistical difference was
yielded with increasing the number of applications. CIM
values for the alcohol-based gel were lower than those
obtained for the liquid soap. Indeed, some statistical dif-
ferences were yielded between CIM values of the liquid
soap and the alcohol-based gel (Table 3a).
Successive combined applications of the liquid soap and
the alcohol-based gel resulted in a fair skin tolerance with
CIM median values ranging 20–30 (Table 2). Surprisingly,
the CIM median values raised with increasing the number
of combined applications (Table 2). However, the range
in CIM values got wider revealing large interindividual
variability. A significant difference (p < 0.01) was yielded
between one and four contacts with the combination of
products. CIM values obtained after successive contacts
with the liquid soap and the alcohol-based gel were signif-
icantly lower than the CIM values obtained following
contact with the liquid soap alone (Table 3b).
Skin protection cream 1 efficacy
SPC 1 was applied onto CSSS before repeat applications of
the liquid soap. (Table 4). Compared to the absence of
SPC 1 application (Table 2), the median CIM values sur-
prisingly dropped after SPC 1 application showing, how-
ever, no significant change. On the overall, CIM median
values remained in the range 35–50 suggesting a fairly
good skin tolerance when SPC 1 was applied before the
liquid soap. However, the range of CIM values became
broader, indicating that the CSSS harvested from some
volunteers were reactive to this combination of products.
In another assessment, SPC 1 was applied before repeat
applications of the alcohol-based gel (Table 4). A marked
decrease in CIM median values was observed. Indeed,
they dropped below 20 indicating some damage to the
SC. A significant difference (p < 0.05) was reached at the
fourth application of the alcohol-based gel when SPC1
has been applied or not beforehand (Tables 2 and 4).
The same procedure was performed with SPC 1 applica-
tion before repeat applications of both the liquid soap
and the alcohol-based gel (Table 4). A decrease in CIM
median values was observed corresponding to an irritant
potential of this combination. Significant differences
between CIM values were yielded at the third application
(p < 0.05) and at the fourth application (p < 0.01) when
comparing SPC 1 application or not (Tables 2 and 4).
Skin protection cream 2 efficacy
SPC 2 was applied onto CSSS before repeat applications of
the liquid soap. (Table 5). The CIM median values
increased when SPC 2 was applied beforehand. A signifi-
cant difference (p < 0.01) was reached for one single
Table 2: CIM data (median and range) obtained following a single or repetitive 10-min contact time with the liquid soap, the alcohol-
based gel and both products successively
Number of
 contacts
Liquid soap Alcohol-based gel Liquid soap and alcohol-
based gel
Median Range Median Range Median Range
1 61.7 42.3 – 71.3 32.9 8.9 – 39.9 21.4 -2.9 – 27.1
2 61.8 51.2 – 69.1 37 8.9 – 48.5 22.3 6.5 – 44.1
3 56.3 44.5 – 80.9 45.6 -5.9 – 53.2 26.9 10.2 – 33.5
4 58.4 43.9 – 66.8 40.1 24.9 – 67.1 30.7 -13.7 – 59.7Journal of Occupational Medicine and Toxicology 2008, 3:15 http://www.occup-med.com/content/3/1/15
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application of the liquid soap (Tables 2 and 5). When
repeat applications of the liquid soap were performed, no
significant difference was yielded. Interestingly enough
the skin tolerance of this combination of products
appeared good with a very high CIM median value above
70.
SPC 2 was also applied on CSSS before repeat applications
of the alcohol-based gel (Table 5). The CIM median values
were above 40, suggesting an overall good skin tolerance.
SPC 2 application showed a significant improvement (p <
0.01) in the skin tolerance for a single application of the
alcohol-based gel.
SPC 2 was applied before repeat applications of the com-
bination of the liquid soap and the alcohol-based gel
(Table 5). Compared to controls (Table 2), the CIM values
were significantly improved when SPC 2 was applied onto
CSSS (p < 0.001) for one application and for two applica-
tions of the offending products (p < 0.01). Starting from
the third application, only a protective trend of SPC 2 was
highlighted.
Discussion
In the present study, cumulative irritancy tests were per-
formed on CSSS for testing SPC efficacy. The bioassays
were conducted in a way close to realistic conditions
encountered at the workplace in medical settings. The rat-
ing methods were performed against controls in absence
of SPC. The validity of the bioassays was previously estab-
lished [17-24]. In general, the SC response in corneosurf-
ametry and corneoxenometry shows some interindividual
Table 3: 
a. Statistical comparison between CIM data after a single or several contacts with the alcohol-based gel and the liquid soap. 
Liquid soap
number of
  contacts
Alcool-based gel
 Number of contacts
1234
1* * * * * ** *
2* * * * * ** ** *
3* * * * * * N S*
4 *** ** NS NS
b. Statistical comparison between CIM data after a single or several contacts with the combination of liquid soap with alcohol gel (LS+AG) and the 
liquid soap. 
Liquid soap
number of 
 contacts
Liquid soap and alcohol-based gel
 Number of contacts
1234
1* * * * * ** *N S
2 *** *** *** *
3 *** ** ** NS
4 *** ** ** NS
* p < 0.05 ** p < 0.01 *** p < 0.001 NS: not significant.
* p < 0.05 ** p < 0.01 *** p < 0.001 NS: not significant.
Table 4: CIM data (median and range) obtained following a single or repetitive 10-min contact time with the liquid soap and/or the 
alcohol-based gel following beforehand one single homogeneous application of SPC1 on the CSSS.
Number of
 contacts
SPC 1 + liquid soap SPC 1 + alcohol-based
 gel
SPC 1 + liquid soap
 and alcohol-based gel
Median Range Median Range Median Range
1 37.4 3.7 – 63.3 13.15 -15.5 – 60.8 21.34 0.2 – 32.3
2 47.5 2.9 – 83.5 15.4 -9.9 – 53.9 10.7 -22.7 – 31.6
3 49.7 14.3 – 64.3 18 -6.3 – 67.2 -3.1 -23 – 32.9
4 42.9 15.9 – 68.4 15.5 -17.5 – 55.1 1.5 -33.4 – 32.2Journal of Occupational Medicine and Toxicology 2008, 3:15 http://www.occup-med.com/content/3/1/15
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variability related in part to the perception of sensitive
skin [25]. Similar variations in data range have been
reported for other methods testing SPC [11]. These find-
ings highlight the difficulty in rating the clinical value of
SPC because the interindividual variability shown by dif-
ferent models share some relevance to the in vivo situa-
tion.
There are two main conceptual ways for ensuring that irri-
tants and allergens do not penetrate into the skin. Some
SPC are expected to prevent the penetration of the xenobi-
otic by a shielding mechanism. Otherwise, the offending
compounds can be sequestrated and neutralized by the
SPC in order to avoid their uptake by the SC. This latter
mechanism can involve some chemical interactions
between the xenobiotic and some SPC compounds.
The liquid soap and the alcohol-based gel were formu-
lated in order to be mild for the skin. Their application on
CSSS indicated a good skin tolerance. The liquid soap was
indeed composed of non-ionic surfactants, selected for
their good compatibility with the skin [1]. Moreover,
allantoin, panthenol and hydrolysed wheat protein
(Table 1) claim anti-irritant properties [26,27] that could
further increase the global skin tolerance. The alcohol-
based gel was similarly well tolerated on CSSS. This was
probably related to the presence of panthenol and other
moisturizing compounds like glycerol and lactic acid [27-
29]. On the overall, a lower skin tolerance was observed
for the alcohol-based gel compared to the liquid soap in
their repeat applications. This finding is at variance with
other works [3,30] suggesting that alcohol solutions were
generally better tolerated than some disinfectant sur-
factants. It should be mentioned that these latter findings
were carried out using sodium laureth sulphate surfactant
that was more aggressive to the skin than the non-ionic
surfactants used in the present study.
The combined application of liquid soap and alcohol-
based gel showed a good skin tolerance. Tolerance was
nevertheless lower than that of the liquid soap and alco-
hol gel used separately. One hypothesis, already raised in
the literature [2], suggests that surfactants used initially
damage the lipid structure of the SC, making it possible
alcohol to infiltrate deeper SC layers. One single com-
bined application of the two offending products, how-
ever, presents a better antiseptic potential, and thus is
recommended when aseptic conditions are mandatory
[3].
The beforehand use of SPC 1 in irritancy tests showed an
uncertain benefit. Indeed, a decreased skin tolerance was
observed following its use before application of the liquid
soap. This decline was accentuated when the alcohol-
based gel was further applied and indicated a marked
potential irritant effect when using the liquid soap and the
alcohol-based gel combination. Interestingly enough, the
three products (SPC 1, soap and gel) used singly were bet-
ter tolerated than when applied in combination. In fact,
some interactions between products can generate com-
pounds presenting irritation properties [7,13]. Therefore,
it was already reported that a given BC should be specific
to the specific irritants.
Positive aspects of SPC use are acknowledged, but some
negative effects can occur [7-9]. Their effects depend on
their composition and galenic presentation. For instance,
preservatives and fragrances [8] can induce irritation and
allergic contact dermatitis. In our study, SPC 1 contained
parabens as preservatives (Table 1). They are responsible
for some allergic potential [4]. The choice of the emulsifi-
ers can also influence the irritant character of the SPC. In
SPC 1, propylene glycol may be responsible for some irri-
tation properties [31]. It is also reported that hydrophobic
or hydrophilic properties of SPC could increase the skin
penetration of irritant substances7 and thus accentuate
their harmful effects.
Contrasting with SPC 1, SPC 2 showed a benefit when
applied beforehand the application of the liquid soap and
the alcohol-based gel. SPC 2 presented a barrier effect
against potentially irritant products. Its protective effect
can be allotted to its composition in various ingredients
including Butyrospermum parkii exhibiting a strong
hydrating capacity [32], and glycerol known to be a effec-
tive humectants [33], and emollients.
Table 5: CIM data (median and range) obtained following a single or repetitive 10-min contact time with the liquid soap and/or the 
alcohol-based gel following beforehand one homogeneous application of SPC2 on the CSSS.
Number of 
contacts
SPC 2 + liquid soap SPC 2 + alcohol-based
 gel
SPC2 + Liquid soap and alcohol-based gel
 alcohol-based gel
Median Range Median Range Median Range
1 77 64.4 – 84 56.42 33 – 85 45.9 38.6 – 59.5
2 73.1 36 – 82 42.7 -2.8 – 76 34.7 27.3 – 40.3
3 74.2 6.9 – 81.2 48.9 18.3 – 68.7 32.6 20.2 – 43.8
4 71.3 14.5 – 79.4 41.3 2.2 – 70.4 34.8 13 – 44.2Journal of Occupational Medicine and Toxicology 2008, 3:15 http://www.occup-med.com/content/3/1/15
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It is likely that the combination of the 2 offending prod-
ucts used in the present study alter both the SC lipids and
the skin barrier function [34]. The SPC are expected to
exert a preventive effect that is different from products
aiming at the skin barrier repair after degradation [35-37].
Conclusion
This study highlights that corneoxenometry and corneo-
surfametry bioessays may be conveniently used to com-
pare the protection afforded by SPC application against
irritant compounds to the skin. They avoid animal testing
and toxicological hazards in human testing. They are
cheap, rapid and reproductible. In this study, they were
used in conditions relevant with the conditions experi-
enced in medical settings.
Contrasting effects were obtained with the two BC sug-
gesting that a protective effect may be quite specific for the
chosen noxious products. Any BC can be protective
against a given type of irritant, and conversely inactive
against other types of irritants or even increasing the irri-
tant properties of products depending on generated bio-
chemical interactions.
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